Viewing Study NCT06757894


Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2026-02-01 @ 10:58 PM
Study NCT ID: NCT06757894
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-01-03
First Post: 2024-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma
Sponsor: Sun Yat-sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Follicular Lymphoma (FL) View
Keywords: